Nabil S Andrawis MD PhD
Burke InternalMedicine, Inc. ManassasClinicalResearchCenter
Join to View Full Profile
5631 Burke Centre PkwySte ABurke, VA 22015
Phone+1 703-250-5171
Fax+1 703-250-5170
Dr. Andrawis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 1991 - 1994
Ain Shams University Faculty of MedicineClass of 1976
Certifications & Licensure
DC State Medical License 1994 - Present
VA State Medical License 1995 - 2026
Awards, Honors, & Recognition
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2011
Clinical Trials
- A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease Start of enrollment: 2011 Nov 01
- Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Join now to see all
Publications & Presentations
PubMed
- Aprocitentan for Blood Pressure Reduction in Black Patients.John M Flack, Markus P Schlaich, Michael A Weber, Mouna Sassi-Sayadi, Krzysztof Narkiewicz
Hypertension. 2025-04-01 - Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial.Deepak L Bhatt, Harold E Bays, Michael Miller, James E Cain 3rd, Katarzyna Wasilewska
Nature Medicine. 2024-06-01 - 17 citationsTolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: A 12-week, randomized, plac...Aditi R Saxena, Juan P Frias, Donal N Gorman, Rene N Lopez, Nabil Andrawis
Diabetes, Obesity & Metabolism. 2023-10-01
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
